Wednesday, June 14
| Start | End | Title |
| Patient Meeting Session I | ||
| 13:45 | 14:15 | Holger Prokisch: State of the art in the diagnosis of mitochondrial disorders |
| 14:15 | 15:00 | Thomas Klopstock: New therapies, current trials, future developments |
| 15:00 | 15:30 | Grainne Gorman: Rehabilitation in mitochondrial diseases |
| 15:15 | 16:30 | Ask the Mito Doc (Thomas Klopstock, Jan Smeitink, Laurence Bindoff, Bobby McFarland, Shamima Rahman, Mirian Janssen, Holger Prokisch) |
| 16:30 | 17:00 | Coffee Break |
| 17:00 | 18:00 | Living with a mitochondrial disease (combined session for EUROMIT2017 and Patient meeting) |
| 17:00 | 17:30 | Shanalle Hamilton |
| 17:30 | 18:00 | Rachael Wells |
Thursday, June 15
| Start | End | Title |
| Session VIII - Therapeutic strategies for mitochondrial diseases-part 2 (combined session for EUROMIT2017 and Patient meeting) |
||
| 09:00 | 09:30 | Michio Hirano: Development of a Pharmacological Therapy for Thymidine Kinase 2 Deficiency |
| 09:30 | 10:00 | Mary Herbert: IVF-based technologies to prevent germline transmission of mtDNA disease |
| 10:00 | 10:30 | Jan Smeitink: Mitochondrial disease small molecule drug development |
| 10:30 | 11:00 | Coffee Break |
| 12:00 | 13:00 | Lunch |
| Patient Meeting - Session II | ||
| 13:00 | 13.30 | Michelangelo Mancuso: Registries and natural history studies |
| 13:30 | 14:30 | Doug Turnbull: Mitochondrial replacement: state of the art |
| 14:30 | 15:30 | Piero Santantonio and Phil Yeske: The IMP Patient Register and the role of Patient Advocacy Groups |
| 15:30 | 16:00 | Coffee Break |
| 16:00 | 17:00 | S. Becker, M. Löffler: The IMP Quality Of Life study pilot in Germany |
| 17:00 | 17:30 | Chris Verhaak: Psychological impact of the m. 3243A>G mutation |
| 17:30 | 18:00 | Jan Smeitink: Final remarks |
If you have any questions please contact us at euromit2017@gmail.com